
Jack Mosley: ‘People who never knew my dad felt like they had lost a friend'
Weight loss was a theme that ran through his projects – from playing the guinea pig for intermittent fasting and ingesting tapeworms in a bid to lose fat, to writing books that popularised the 5:2 and Fast 800 diets, which helped the masses shift the scales.
Now, seven years after becoming a doctor and a year on from his father's death, his son Jack, the only one of his four children to become a doctor, is continuing to follow in his father's footsteps with his book Food Noise. It navigates the new world of GLP-1 weight-loss drugs, better known as Wegovy, Ozempic (technically a Type 2 diabetes drug) and Mounjaro. He explores how they work, the risks and benefits, and how to use them safely.
'My dad was clearly a massive inspiration to me,' Jack says. 'He would have written a book on weight loss medications had he not passed away.' The book is dedicated to Michael, whom Jack describes as a 'guiding light'.
'He could see that the GLP-1s could be a massive breakthrough in obesity,' he says. 'We talked about them around the dinner table. He was very excited about them but could see they were a tool in the toolbox to combat obesity, rather than replacing the toolbox altogether.'
'When he passed away, we ourselves as a family didn't really know the scale of how many people he made such a difference to,' Jack says. 'People who never knew him felt like they had lost a friend. I think that was such a testament to how much help he gave to so many people.'
Jack spoke to his mother, the GP Dr Clare Bailey Mosley, brothers Alex, 34, and Dan, 30, both management consultants in the City, and sister Kate, 25, a lawyer, about how best to continue his legacy of helping people to improve their health.
The book was born out of that discussion. 'One of the ways was to spread his message through Food Noise,' he says. It became a family project – he planned out the chapters with his mum during a packed train journey through Austria, and she contributed 50 recipes for it.
'I thought I couldn't beat the skinny gene'
Outside of discussions with his father, Jack had developed his own interest in Britain's obesity crisis and weight loss while studying medicine at Newcastle University, where he wrote his dissertation on diabetes with a particular focus on weight loss maintenance.
'One of the things that most interested me is the fact that a poor diet – now the number-one risk factor for early death worldwide – is at the heart of so many chronic diseases,' he says.
Then, while working as a junior doctor, the naturally slim-built Jack experienced first hand how easy it was to pile on weight. He gained 2st 5lb (15kg) in his first year working in a hospital, bringing his weight to 15st 11lb (100kg), which he puts down to stress, over-zealous snacking habits and a lack of exercise.
'I thought I couldn't beat the skinny gene, but it turns out that I could put on weight much more easily than I thought,' he says. 'I was really stressed, as I was trying to work out my place in the hospital – no amount of medical school can teach you what it's actually like to work as a junior doctor.
'The other thing was that I had a long commute in the car. I was driving over an hour there and sometimes more than an hour back home. I got into the habit of munching on sweets in the car. Like my dad, I have a sweet tooth.'
Haribos were a particular vice, as was snacking on chocolate generously gifted by patients and feasting on a family-sized bag of Doritos with salsa on the sofa, which he could get through 'in half an hour'. 'Then, I'd be having these beige lunches with my colleagues – hospital canteens are not known for their good food,' he says.
'I managed to get my first two fillings,' Jack says. 'My fiancée is a dentist, so I wasn't too impressed by that.'
However, he shed the weight quickly after he settled into his job, returned to planning his meals more carefully, started exercising regularly and banned himself from buying large packets of sweets. 'I know I'll just eat the whole thing in an hour, so I'll buy sweets sometimes but a smaller pack,' he adds.
Obesity crisis 'is not a collapse in willpower'
While he is now a healthy weight, Jack is in the minority. More than half the population (64 per cent) are now overweight or obese.
'In the 1960s, 1 or 2 per cent of people in the UK were living with obesity – now it is 30 per cent,' Jack notes. 'This is not a collapse in willpower; there has to be something going on in the environment for this to happen.'
Instead, it's a result of the dramatic change in how we're exposed to food on a daily basis. There has been an explosion in the mass manufacturing of cheap, highly calorific and highly palatable food; snacking (unheard of in the 1960s) has become the norm; and there's a fast food outlet on seemingly every street, as Jack details in the book.
'A lot of people do have good intentions to stick to a healthy diet, but in this food environment, that can be so easily derailed,' he says.
'We're surrounded by foods that are designed to be over-eaten. They're designed to reach the bliss point, where you have this perfect combination of sugar, salt, starchy carbs, fat and flavourings that just sends our brains haywire.
'A lot of these foods are actually really addictive and they light up the pleasure centres in our brain in a similar way that smoking or alcohol do.'
The weight-loss jabs silencing 'food noise'
The term 'food noise' has gained popularity against this backdrop of the obesity crisis and the rise of weight-loss drugs, which work by effectively 'muting' our desire to be constantly eating.
'Food noise is not a scientific term,' Jack notes. 'It refers to your cravings, your internal food monologue. It's that constant chatter about food. It can be that voice that's telling you to grab that extra slice of chocolate cake or packet of crisps, sometimes even when you're not hungry.'
While some people rarely 'hear' food noise, others live with constant thoughts about their next meal, imagining the taste of food and wanting to eat, he says. While food noise is key to our survival – it tells us when we're hungry and need to eat for fuel – it is also the driving force behind overeating, he explains.
'Weight-loss drugs brought the term to prominence because they are so effective at silencing, or at least quietening, that food noise, because they work not just by reducing your appetite but also reducing your cravings,' he says.
He notes that some users have reported not only being drawn to healthier foods but feeling nauseated at the thought of consuming alcohol or their favourite sugary, fatty food.
'I like to look at these drugs like noise-cancelling headphones, so you put them on, you can go about your day, you can ignore the siren call of processed junk,' he says.
'But when you stop the medication, this all comes racing back, so it's really important that you get the right nutritional strategies to quieten that food naturally.'
'I adopt a diet-first approach,' he says. While taking the drugs, and after coming off of them, he recommends following the Mediterranean diet, including plenty of vegetables, protein and fermented food, and exercising regularly, particularly strength-based workouts to maintain and increase muscle mass.
'I think that these medications are for people who are living with obesity and potentially obesity-related diseases,' Jack notes. 'People who are regarded as more of a healthy weight should not be taking these drugs. They're not a cosmetic drug and they're not a drug to get you 'beach body ready'.'
Treating obesity on the front line
Jack has now been a doctor for seven years, starting off in A&E in the north-west of England, and then taking on emergency units in Melbourne and the Australian Outback, before returning to the UK to work as a GP registrar, a role that sees many patients enter the treatment room because of weight-related conditions.
'There is a huge amount of disease related to obesity, and we see them all the time,' he says. 'A lot of primary care is treating these diseases before they become raging infernos.'
Heart disease, Type 2 diabetes, high blood pressure, cancer, obstructive sleep apnoea and dementia are just some of the conditions that are being fuelled by Britain's bulging waistline.
'A lot of these diseases are linked to inflammation, which can be as a result of obesity, poor diet and a lack of exercise,' he explains. 'Inflammation in the body is like a smouldering fire that's just slowly damaging your organs and body over time.'
'There has been a rise in colon cancer, especially in younger people and realistically, that is very likely to be tied to the rise in processed junk foods and all this inflammation going on in the body,' Jack adds.
'Many of these diseases can be prevented by following a healthy lifestyle,' he notes.
Continuing the legacy
Food Noise became an instant Sunday Times bestseller, of which Michael had nine in his lifetime. 'I'm absolutely delighted about that,' Jack says.
'[My mother] was so happy, she was really, really pleased, and it's been really nice to be able to work with her on some of this,' he says.
Looking forward, he plans to keep working part-time as a GP registrar but has his sights on future books and projects related to how we can be living healthier lives.
'I absolutely loved writing this book,' he says. 'I'm thinking about diet and exercise, and even things like sleep. I think that's something that hasn't had enough focus until more recently, especially within medicine itself. We'll see what the future holds.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
3 minutes ago
- The Independent
Warning over ‘life-threatening' fake Ozempic jabs sold by bogus online pharmacies
Warnings have been issued over fake weight loss jabs that could be 'life-threatening' after thousands of fraudulent online pharmacies were uncovered. Fake versions of Ozempic, a popular brand of weight loss jab, were being sold for as little as £13.70 per dose, along with counterfeit versions of other brands, including Rybelsus and Metformin pills, being offered from 24p. The UK's medicines regulator said taking bogus medications could not only make people ill, but in some cases could be fatal. Researchers from cybersecurity company Gen, who conducted the research, warned of the 'dangerous' threat of the global scam involving more than 5,000 fake pharmacy sites this year, which they say are being run by criminal networks. It comes amid the rapid rise of weight-loss medication in the UK - with around 1.5 million people, 4 per cent of households, currently using them. Gen also found fake Viagra, a medicine used to treat erection issues, and unregulated fertility pills being sold. The company said lab tests found no active ingredient in a third of the drugs tested. Andy Morling, deputy director of criminal enforcement at the Medicines and Healthcare products Regulatory Agency (MHRA), told The Independent: 'Buying medicines from illegal suppliers significantly increases the risk of receiving products that are either falsified or not licensed for use in the UK. Products purchased in this way will not meet the MHRA's strict quality and safety standards, and taking such medicines may put one's health at risk.' 'Fake prescription and over-the-counter medicines not only fail to work but can also make you sick. Even worse, in the most severe cases, they may contain dangerous ingredients, potentially leading to death,' the regulator added. The researchers warned that the 'alarmingly' polished websites, complete with bogus customer service information, detailed product pages, and looked similar to legitimate online pharmacies. But many were detected as fakes because they used AI to create reviews, health blogs, live chat support and manipulated search results. As well as the health implications, the researchers said UK customers risked their details and identity being stolen by the sites. Siggi Stefnission, cyber safety chief technology officer at Gen, warned: 'Purchasing pharmaceuticals from untrusted online retailers is a serious danger, both to individual health and to someone's digital safety. 'From a public health perspective, counterfeit or unregulated drugs can be ineffective or even life-threatening. It's critical that consumers only use licensed, reputable online pharmacies to protect themselves from cybercrime and potential physical harm.' The popularity of weight-loss jabs has soared in the past year, with the NHS 's top doctor, Sir Stephen Powis, saying they could soon become among the most commonly used drugs. Both Ozempic and Rybelsus, which have the active ingredient semaglutide, are not licensed as a weight loss treatment. Instead they are designed to treat people with type 2 diabetes but both are sometimes prescribed off-label to treat weight loss. However, popular weight loss jabs Wegovy, which has the same active ingredient, and Mounjaro, which uses the active ingredient tirzepatide, are both licensed in the UK for the treatment of weight loss. Gen explained that criminals are taking advantage of people looking for a fast and discreet way to get high-demand weight loss treatment, among other medications that are often sought quickly, privately, or at a lower cost. Alongside the vast network of more than 5,000 web domains selling the in-demand drugs fraudulently, Gen said, this year alone, it has already blocked 1 million attacks coming from these sites against unsuspecting online shoppers. Laura Wilson, director at Royal Pharmaceutical Society, said fake and illegal online pharmacies 'are a growing threat to patient safety'. She explained that fraudulent medicines may be out of date, substandard or contain 'dangerous' substances. Gen said its team is currently working on testing fake medications to work out what exactly they are made of. The company advised consumers to watch out for low-cost offers for prescription-only drugs, missing contact information, requests for cryptocurrency payments, unsecured checkout processes, and prompts for sensitive personal, medical, or financial data. Novo Nordisk, the company that makes Ozempic and Rybelsus, said it was aware that counterfeit Ozempic products are being sold in the UK and is working with health authorities, including the MHRA, to investigate the 'critical issue'. It advised people to examine packaging and pens closely before using them. Mr Morling said the MHRA is cracking down on the issue of fake medicines and pharmacies, with offenders potentially facing criminal investigation and prosecution.


Fashion United
17 minutes ago
- Fashion United
Paul Smith extends Fashion Residency programme to US with CFDA
British designer Paul Smith has expanded his brand's existing Fashion Residency programme to students in the US. In partnership with the Council of Fashion Designers of America (CFDA), for the initiative's second edition the Paul Smith Foundation will be selecting one American designer to join the residency at Studio Smithfield in London. The inaugural US participant, who will be part of the Paul Smith's Foundation x CFDA Designer-in-Residence, will join six UK-based designers in receiving a 400 square foot studio space for 12 months, supported by Projekt. Each designer will also receive mentoring from industry leaders, business-planning training, a visa, flights and living expenses. Applications for the second cohort of the programme have now been opened, with shortlisted candidates associated with the CFDA-led arm to begin interviews in September 2025. Designer Paul Smith will oversee the selection process alongside CFDA president, Steven Kolb, and vice president of program strategies/education and sustainability initiatives at CFDA, Sara Kozlowski. Launched in 2024, Paul Smith founded the Fashion Residency at Studio Smithfield programme alongside the Mayor of London and Projekt. Through it, select young designers are given access to set workspace and a training programme, the latter designed by the Paul Smith's Foundation, which matches participants with industry professionals. In a statement, Kolb said: 'Fashion is truly a global business, and an opportunity such as this will provide one American talent with invaluable experience and exposure in an international market. The chance to work alongside peers in the UK fosters creative exchange, builds cross-cultural understanding, and strengthens our industry as a whole. We are deeply grateful to Sir Paul Smith for his continued collaboration and dedication to nurturing the next generation of talent.'


BBC News
34 minutes ago
- BBC News
Innovative device at Royal Surrey improves prostate cancer result
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for Histolog Scanner allows surgeons at Royal Surrey County Hospital to assess the prostate for cancerous tissue in real-time during surgery rather than wait for post-operation trust says the technology enables surgeons to remove additional tissue if required, potentially reducing the risk of leaving behind cancerous cells. Wissam Abou-Chedid, consultant urological surgeon, said: "This technology marks a real leap forward in prostate cancer surgery." He said: "For the first time, we can assess tissue in real time while the patient is still on the operating table – allowing us to make immediate, informed decisions that improve cancer control without putting quality of life at risk."It means fewer patients needing radiotherapy afterwards, and more men retaining their continence and sexual function."Royal Surrey's urology clinical director, Dimitrios Moschonas, said the scanner strengthens the hospital's reputation as a national leader in prostate cancer treatment and robotic surgery."As the highest-volume single-site centre for robotic prostatectomy in the UK, Royal Surrey continues to lead with pioneering initiatives," he said. In May 2023, Royal Surrey's urology team set a record, performing 12 robotic prostatectomies in a single day. In August, the team was shortlisted for an HSJ award for its catheter scheme to assist prostate cancer patients following robotic surgery. Patients are taught how to safely remove their own catheters at home, avoiding return trips to the hospital.